Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any retinopathy caused by variants in the LRIT3 gene.
Biomarker and diagnostic research for LRIT3-related retinopathy has been reported in the published literature.
No clinical trials have been registered for LRIT3-related retinopathy.
210 publications have been identified in PubMed for LRIT3-related retinopathy. Kisho has analyzed 81 by research type. Research spans Review / Meta-Analysis (53%), Basic Science / Preclinical (22%), and Epidemiology / Natural History (15%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 43 | 53% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 6:00 PM UTC
Common questions about LRIT3-related retinopathy
Laboratory research
18 |
22% |
Disease patterns and progression | 12 | 15% |
Patient case studies | 3 | 4% |
New treatment approaches | 3 | 4% |
Other research | 1 | 1% |
Testing and diagnosis research | 1 | 1% |
Mukundan A (2026). [PMID: 41316839](https://pubmed.ncbi.nlm.nih.gov/41316839/). *Ocul Immunol Inflamm*. [Review / Meta-Analysis]
Marmor MF (2026). [PMID: 41232611](https://pubmed.ncbi.nlm.nih.gov/41232611/). *Ophthalmology*. [Review / Meta-Analysis]
Hall BP (2025). [PMID: 40962246](https://pubmed.ncbi.nlm.nih.gov/40962246/). *Prog Retin Eye Res*. [Review / Meta-Analysis]
Bora K (2025). [PMID: 40778701](https://pubmed.ncbi.nlm.nih.gov/40778701/). *Invest Ophthalmol Vis Sci*. [Basic Science / Preclinical]
Realini G (2025). [PMID: 41205411](https://pubmed.ncbi.nlm.nih.gov/41205411/). *Redox Biol*. [Basic Science / Preclinical]
Petersen-Jones SM (2025). [PMID: 40461693](https://pubmed.ncbi.nlm.nih.gov/40461693/). *Eye (Lond)*. [Review / Meta-Analysis]
Ghaleb R (2025). [PMID: 40089030](https://pubmed.ncbi.nlm.nih.gov/40089030/). *Surv Ophthalmol*. [Review / Meta-Analysis]
Zhang Y (2025). [PMID: 39794828](https://pubmed.ncbi.nlm.nih.gov/39794828/). *Cell Commun Signal*. [Gene Therapy / Novel Therapeutics]
Morris CA (2025). [PMID: 40670232](https://pubmed.ncbi.nlm.nih.gov/40670232/). *Trends Neurosci*. [Review / Meta-Analysis]
Méjécase C (2025). [PMID: 40365019](https://pubmed.ncbi.nlm.nih.gov/40365019/). *Front Cell Dev Biol*. [Basic Science / Preclinical]